Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy

BACKGROUND: Epidemiological evidence suggests that anti-inflammatory and immunomodulatory properties of statins may reduce the risk of infections and infection-related complications. OBJECTIVE: We aimed to assess the impact of prior statin use on coronavirus disease (COVID-19) severity and mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitacchione, Gianfranco, Schiavone, Marco, Curnis, Antonio, Arca, Marcello, Antinori, Spinello, Gasperetti, Alessio, Mascioli, Giosuè, Severino, Paolo, Sabato, Federica, Caracciolo, Maria M., Arabia, Gianmarco, D'Erasmo, Laura, Viecca, Maurizio, Mancone, Massimo, Galli, Massimo, Forleo, Giovanni B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Lipid Association. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833194/
https://www.ncbi.nlm.nih.gov/pubmed/33390341
http://dx.doi.org/10.1016/j.jacl.2020.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833194/
https://www.ncbi.nlm.nih.gov/pubmed/33390341
http://dx.doi.org/10.1016/j.jacl.2020.12.008

Ejemplares similares